As of 2025-06-20, the EV/EBITDA ratio of Translate Bio Inc (TBIO) is -0.10. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TBIO's latest enterprise value is 2.78 mil USD. TBIO's TTM EBITDA according to its financial statements is -27.91 mil USD. Dividing these 2 quantities gives us the above TBIO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.0x - 12.4x | 12.2x |
| Forward P/E multiples | 20.2x - 43.4x | 31.8x |
| Fair Price | (20,608.28) - (12,688.48) | (22,435.92) |
| Upside | -638127.1% - -392932.2% | -694710.6% |
| Date | EV/EBITDA |
| 2025-06-18 | -0.10 |
| 2025-05-30 | -0.10 |
| 2025-05-29 | -0.10 |
| 2025-05-28 | -0.10 |
| 2025-05-13 | -0.10 |
| 2025-05-08 | -0.10 |
| 2025-05-07 | -0.10 |
| 2025-05-06 | -0.10 |
| 2025-05-05 | -0.10 |
| 2025-05-02 | -0.10 |
| 2025-05-01 | -0.10 |
| 2025-04-30 | -0.10 |
| 2025-04-29 | -0.10 |
| 2025-04-28 | -0.10 |
| 2025-04-25 | -0.10 |
| 2025-04-24 | -0.10 |
| 2025-04-23 | -0.10 |
| 2025-04-22 | -0.10 |
| 2025-04-21 | -0.10 |
| 2025-04-17 | -0.10 |
| 2025-04-16 | -0.10 |
| 2025-04-15 | -0.10 |
| 2025-04-14 | -0.10 |
| 2025-04-11 | -0.10 |
| 2025-04-10 | -0.10 |
| 2025-04-09 | -0.10 |
| 2025-04-08 | -0.10 |
| 2025-04-07 | -0.10 |
| 2025-04-04 | -0.10 |
| 2025-04-03 | -0.10 |
| 2025-04-02 | -0.10 |
| 2025-03-31 | -0.10 |
| 2025-03-28 | -0.10 |
| 2025-03-27 | -0.10 |
| 2025-03-26 | -0.10 |
| 2025-03-25 | -0.10 |
| 2025-03-24 | -0.10 |